| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Medicine, Division of Endocrinology and Metabolism (J.A., J.J., J.F.G., S.J.F.), and the Department of Cell Biology (X.Y., S.J.F.), University of Alabama, and the Veterans Affairs Medical Center (J.F.G., S.J.F.), Birmingham, Alabama 35294; the Center for Endocrinology, Metabolism, and Molecular Medicine, Department of Medicine, Northwestern University Medical School (H.G.M., G.B.), Chicago, Illinois 60611; and Immunex Corp. (R.A.B.), Seattle, Washington 98101
Address all correspondence and requests for reprints to: Dr. Stuart J. Frank, University of Alabama, Room 756, Diabetes Research and Education Building, UAB Station, Birmingham, Alabama 35294. E-mail: frank{at}endo.dom.uab.edu
GH, an important growth-promoting and metabolic hormone, exerts its
biological effects by interacting with cell surface GH receptors
(GHRs). The GHR is a single membrane-spanning protein that binds GH via
its extracellular domain. The high affinity GH-binding protein (GHBP),
which corresponds to a soluble form of the GHR extracellular domain,
carries a substantial fraction of the GH in the circulation of various
species and probably has a role in modulation of the hormones
bioavailability. Although in rodents, it is believed that the GHBP is
largely derived by translation of an alternatively spliced GHR
messenger RNA, in humans and rabbits, proteolytic cleavage of the
membrane-anchored receptor releases the GHR extracellular domain, which
is believed to thereby become the GHBP. In this study, we used human
IM-9 lymphocytes and GHR antibodies to study this proteolytic shedding
of the GHBP. As determined by immunoblotting with anti-GHR cytoplasmic
domain serum, addition of phorbol 12-myristate 13-acetate (PMA; 1
µg/ml) to serum-starved cells led to rapid loss (roughly 60% decline
after 1 h; t1/2 =
5 min) of mature GHRs (115140
kDa) from either total cell or detergent-soluble extracts. Loss of
full-length GHRs was accompanied by accumulation of four proteins
(6568 kDa), each reactive with the cytoplasmically directed
antiserum. The pattern of appearance of these GHR ctyoplasmic domain
proteins, the electrophoretic and immunological characteristics of
which are similar to those of a recombinant rabbit GHR mutant that
lacks the extracellular domain, was such that progressively faster
migrating forms were evident between 560 min of PMA exposure.
Treatment with N-ethylmaleimide (NEM; 5 mM),
an agent known to cause GHBP shedding from IM-9 cells, promoted a
similar rapid loss of full-length GHRs and an accumulation of GHR
cytoplasmic domain remnant proteins. PMA-induced, but not NEM-induced,
GHR proteolysis was blocked by the protein kinase C inhibitor,
GF109203X. Both PMA- and NEM-induced receptor proteolysis were,
however, inhibited by the metalloprotease inhibitor, Immunex Compound 3
(minimum effective concentration, 10 µM). Notably, PMA
and NEM also promoted shedding of GHBP into the conditioned medium of
the cells, as determined by a chromatographic [125I]human
GH binding assay; this GHBP shedding was also inhibited by Immunex
Compound 3. These results strongly implicate a member(s) of the
metalloprotease family as a potential GHBP-generating enzyme.
This article has been cited by other articles:
![]() |
G. Kenth, J. A M. Mergelas, and C. G. Goodyer Developmental changes in the human GH receptor and its signal transduction pathways J. Endocrinol., July 1, 2008; 198(1): 71 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, J. Jiang, J. Warram, G. Baumann, Y. Gan, R. K. Menon, L. A. Denson, K. R. Zinn, and S. J. Frank Endotoxin-Induced Proteolytic Reduction in Hepatic Growth Hormone (GH) Receptor: A Novel Mechanism for GH Insensitivity Mol. Endocrinol., June 1, 2008; 22(6): 1427 - 1437. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Yang, J. F. Langenheim, X. Wang, J. Jiang, W. Y. Chen, and S. J. Frank Activation of Growth Hormone Receptors by Growth Hormone and Growth Hormone Antagonist Dimers: Insights into Receptor Triggering Mol. Endocrinol., April 1, 2008; 22(4): 978 - 988. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Loesch, L. Deng, X. Wang, K. He, J. Jiang, and S. J. Frank Endoplasmic Reticulum-Associated Degradation of Growth Hormone Receptor in Janus Kinase 2-Deficient Cells Endocrinology, December 1, 2007; 148(12): 5955 - 5965. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Yang, X. Wang, J. Jiang, and S. J. Frank Role of the Growth Hormone (GH) Receptor Transmembrane Domain in Receptor Predimerization and GH-Induced Activation Mol. Endocrinol., July 1, 2007; 21(7): 1642 - 1655. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Deng, K. He, X. Wang, N. Yang, C. Thangavel, J. Jiang, S. Y. Fuchs, and S. J. Frank Determinants of Growth Hormone Receptor Down-Regulation Mol. Endocrinol., July 1, 2007; 21(7): 1537 - 1551. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Frank, X. Wang, K. He, N. Yang, P. Fang, R. G. Rosenfeld, V. Hwa, T. R. Chaudhuri, L. Deng, and K. R. Zinn In Vivo Imaging of Hepatic Growth Hormone Signaling Mol. Endocrinol., November 1, 2006; 20(11): 2819 - 2830. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Gadd and C. V. Clevenger Ligand-Independent Dimerization of the Human Prolactin Receptor Isoforms: Functional Implications Mol. Endocrinol., November 1, 2006; 20(11): 2734 - 2746. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Loesch, L. Deng, J. W. Cowan, X. Wang, K. He, J. Jiang, R. A. Black, and S. J. Frank Janus Kinase 2 Influences Growth Hormone Receptor Metalloproteolysis Endocrinology, June 1, 2006; 147(6): 2839 - 2849. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Gallardo, C. Arribas, M. Villar, M. Ros, J. M. Carrascosa, C. Martinez, and A. Andres ObRa and ObRe Are Differentially Expressed in Adipose Tissue in Aged Food-Restricted Rats: Effects on Circulating Soluble Leptin Receptor Levels Endocrinology, November 1, 2005; 146(11): 4934 - 4942. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. He, K. Loesch, J. W. Cowan, X. Li, L. Deng, X. Wang, J. Jiang, and S. J. Frank Janus Kinase 2 Enhances the Stability of the Mature Growth Hormone Receptor Endocrinology, November 1, 2005; 146(11): 4755 - 4765. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Cowan, X. Wang, R. Guan, K. He, J. Jiang, G. Baumann, R. A. Black, M. S. Wolfe, and S. J. Frank Growth Hormone Receptor Is a Target for Presenilin-dependent {gamma}-Secretase Cleavage J. Biol. Chem., May 13, 2005; 280(19): 19331 - 19342. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Jiang, X. Wang, K. He, X. Li, C. Chen, P. P. Sayeski, M. J. Waters, and S. J. Frank A Conformationally Sensitive GHR [Growth Hormone (GH) Receptor] Antibody: Impact on GH Signaling and GHR Proteolysis Mol. Endocrinol., December 1, 2004; 18(12): 2981 - 2996. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Edmondson, S. P. Thumiger, G. A. Werther, and C. J. Wraight Epidermal Homeostasis: The Role of the Growth Hormone and Insulin-Like Growth Factor Systems Endocr. Rev., December 1, 2003; 24(6): 737 - 764. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, K. He, M. Gerhart, J. Jiang, R. J. Paxton, R. K. Menon, R. A. Black, G. Baumann, and S. J. Frank Reduced Proteolysis of Rabbit Growth Hormone (GH) Receptor Substituted with Mouse GH Receptor Cleavage Site Mol. Endocrinol., October 1, 2003; 17(10): 1931 - 1943. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Graichen, J. Sandstedt, E. L. K. Goh, O. G. P. Isaksson, J. Tornell, and P. E. Lobie The Growth Hormone-binding Protein Is a Location-dependent Cytokine Receptor Transcriptional Enhancer J. Biol. Chem., February 14, 2003; 278(8): 6346 - 6354. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, K. He, M. Gerhart, Y. Huang, J. Jiang, R. J. Paxton, S. Yang, C. Lu, R. K. Menon, R. A. Black, et al. Metalloprotease-mediated GH Receptor Proteolysis and GHBP Shedding. DETERMINATION OF EXTRACELLULAR DOMAIN STEM REGION CLEAVAGE SITE J. Biol. Chem., December 20, 2002; 277(52): 50510 - 50519. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. van Kerkhof, M. Smeets, and G. J. Strous The Ubiquitin-Proteasome Pathway Regulates the Availability of the GH Receptor Endocrinology, April 1, 2002; 143(4): 1243 - 1252. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Maamra, M. Bidlingmaier, M.-C. Postel-Vinay, Z. Wu, C. J. Strasburger, and R. J. M. Ross Generation of Human Soluble Leptin Receptor by Proteolytic Cleavage of Membrane-Anchored Receptors Endocrinology, October 1, 2001; 142(10): 4389 - 4393. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Guan, Y. Zhang, J. Jiang, C. A. Baumann, R. A. Black, G. Baumann, and S. J. Frank Phorbol Ester- and Growth Factor-Induced Growth Hormone (GH) Receptor Proteolysis and GH-Binding Protein Shedding: Relationship to GH Receptor Down-Regulation Endocrinology, March 1, 2001; 142(3): 1137 - 1147. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, J. Jiang, R. A. Black, G. Baumann, and S. J. Frank Tumor Necrosis Factor-{{alpha}} Converting Enzyme (TACE) Is a Growth Hormone Binding Protein (GHBP) Sheddase: The Metalloprotease TACE/ADAM-17 Is Critical for (PMA-Induced) GH Receptor Proteolysis and GHBP Generation Endocrinology, December 1, 2000; 141(12): 4342 - 4348. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ballesteros, K.-C. Leung, R. J. M. Ross, T. P. Iismaa, and K. K. Y. Ho Distribution and Abundance of Messenger Ribonucleic Acid for Growth Hormone Receptor Isoforms in Human Tissues J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2865 - 2871. [Abstract] [Full Text] |
||||
![]() |
P. Reddy, J. L. Slack, R. Davis, D. P. Cerretti, C. J. Kozlosky, R. A. Blanton, D. Shows, J. J. Peschon, and R. A. Black Functional Analysis of the Domain Structure of Tumor Necrosis Factor-alpha Converting Enzyme J. Biol. Chem., May 5, 2000; 275(19): 14608 - 14614. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Amit, M. B. H. Youdim, and Z.'e. Hochberg Does Serum Growth Hormone (GH) Binding Protein Reflect Human GH Receptor Function? J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 927 - 932. [Abstract] [Full Text] |
||||
![]() |
L. Rui, S. F. Archer, L. S. Argetsinger, and C. Carter-Su Platelet-derived Growth Factor and Lysophosphatidic Acid Inhibit Growth Hormone Binding and Signaling via a Protein Kinase C-dependent Pathway J. Biol. Chem., January 28, 2000; 275(4): 2885 - 2892. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, J. Jiang, J. J. Kopchick, and S. J. Frank Disulfide Linkage of Growth Hormone (GH) Receptors (GHR) Reflects GH-induced GHR Dimerization. ASSOCIATION OF JAK2 WITH THE GHR IS ENHANCED BY RECEPTOR DIMERIZATION J. Biol. Chem., November 12, 1999; 274(46): 33072 - 33084. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Chaffin and R. L. Stouffer Expression of Matrix Metalloproteinases and Their Tissue Inhibitor Messenger Ribonucleic Acids in Macaque Periovulatory Granulosa Cells: Time Course and Steroid Regulation Biol Reprod, July 1, 1999; 61(1): 14 - 21. [Abstract] [Full Text] |
||||
![]() |
T. Amit, O. Bar-Am, F. Dastot, M. B. H. Youdim, S. Amselem, and Z.'e. Hochberg The Human Growth Hormone (GH) Receptor and Its Truncated Isoform: Sulfhydryl Group Inactivation in the Study of Receptor Internalization and GH-Binding Protein Generation Endocrinology, January 1, 1999; 140(1): 266 - 272. [Abstract] [Full Text] |
||||
![]() |
Y. Zhang, R. Guan, J. Jiang, J. J. Kopchick, R. A. Black, G. Baumann, and S. J. Frank Growth Hormone (GH)-induced Dimerization Inhibits Phorbol Ester-stimulated GH Receptor Proteolysis J. Biol. Chem., June 29, 2001; 276(27): 24565 - 24573. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |